Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215481 · ClinicalTrials.gov registry record · NA
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT07215481: Clinical Trial NA study, sponsored by Stanford University.
NCT07215481 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215481, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The main question it aims to answer is: Is this new automated algorithm effective for treating motor symptoms of PD. Fifteen participants are anticipated to be enrolled. Participants are individuals who recently were implanted with DBS in the subthalamic nucleus as part of their regular clinical treatment and are scheduled to have their DBS turned ON for the first time. In addition to their regular clinical visit when their DBS is turned ON by their clinician, participants are tested on DBS settings determined by Illumina 3D (an automated algorithm). Participants are tested on these different settings across different motor tasks, including walking and finger tapping, as well as answering questionnaires. The experiment is expected to last 1 or 2 days; this is not a longitudinal or long-term trial. Participants return to their usual DBS settings once they leave the clinic.
Primary Outcome
Quantitative Digitography (QDG) Mobility Score is a single score representing a participant's overall movement proficiency by combining performance across different aspects of movement including speed, frequency, amplitude, and rhythmicity measured using an engineered Keyduo QDG device during an alternating finger pressing and releasing with the index and middle finger. It is represented by a single value between 0 and 100 for each hand, where 100 represents ideal performance. The primary outcom
Interventions
- DEVICE Shame Control (Baseline)
- DEVICE Standard of Care Deep Brain Stimulation
- DEVICE Illumina 3D Deep Brain Stimulation
- DEVICE Illumina 3D Deep Brain Stimulation Reduced Amplitude
- DEVICE Illumina 3D Deep Brain Stimulation Higher Amplitude
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-12 |
| Phase | NA |
What is known before NCT07215481 opens enrollment
NCT07215481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Shame Control (Baseline) is the first listed.
NCT07215481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07215481 about?
NCT07215481 is a clinical study titled "Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease". The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The main question it aims to answer is: Is this new automated algorithm effective for treating motor sy...
What is the current status of trial NCT07215481?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-06. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07215481?
The interventions under investigation include: Shame Control (Baseline) (DEVICE), Standard of Care Deep Brain Stimulation (DEVICE), Illumina 3D Deep Brain Stimulation (DEVICE), Illumina 3D Deep Brain Stimulation Reduced Amplitude (DEVICE), Illumina 3D Deep Brain Stimulation Higher Amplitude (DEVICE).
Who is sponsoring clinical trial NCT07215481?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07215481's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia